跳至主要内容
临床试验/NCT01813656
NCT01813656终止4 期

A Multiple-Center, Randomized, Double-Blind Study of Aripiprazole for Treatment of Methamphetamine Dependence

Wei Hao1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
10
试验地点
1
主要终点
abstinent time of Methamphetamine addict

研究概览

简要总结

Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. Aripiprazole are Second generation antipsychotics,but have different pharmacological effects of neurotransmitters.To determine whether mirtazapine would reduce methamphetamine use among mehtamphetamine addicts.

详细描述

Methods:A Multiple-Center, Randomized, Double-Blind.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients,Diagnostic and Statistical Manual of Mental Disorders 4thed. (DSM-IV) criteria for Methamphetamine dependence.
  • Must sign a Information consent form.
  • Required to provide detailed address and phone number

排除标准

  • Serious organic disease.
  • Suicide ideation or hurt others.
  • Taking antipsychotic within two weeks before.
  • drug allergy to Risperidone or Aripiprazole.
  • pregnancy and breastfeeding women.

研究组 & 干预措施

Aripiprazole

Experimental

Aripiprazole arm,5mg/pill,10mg/day.last12weeks.

干预措施: Aripiprazole (Drug)

Sugar pill

Placebo Comparator

placebo arm,5mg/pill,10mg/day,last12weeks

干预措施: placebo (Drug)

结局指标

主要结局

abstinent time of Methamphetamine addict

时间窗: up to 3 months

methamphetamine-positive urine test results,self-reports of substance use

次要结局

  • number of Participants with Adverse Events as a Measure of Safety and Tolerability(up to 3 months)

研究者

发起方
Wei Hao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wei Hao

The Second Xiangya Hospital of Cental South University

Central South University

研究点 (1)

Loading locations...

相似试验